Skin sensitization
In 2006-7 a number of cases emerged in Europe with patients showing signs of severe contact dermatitis on their legs, buttocks and back, which was resistant to topical treatment. Through research carried out by dermatologists, it was found that the patients had all purchased leather furniture prior to developing the rash and the unusual dermatitis patterns could be related to sitting position and style of furniture purchased1. The cases seen in countries such as the UK, Finland and France were traced back to furniture manufactured in China. Patch tests were carried out with a number of allergens associated with leather and these confirmed that the cases of dermatitis were most likely to have been caused by the presence of DMF in the furniture, resulting in a painful rash at levels as low as 1ppm2. The reaction causing the dermatitis was found to be allergic, as not all people in contact with the furniture showed signs of a rash, and patients often stated that they had no direct contact with the leather, only having sat on the furniture fully clothed3.
It was found that anti-mould sachets were being placed in the packaging, or being stapled to the wooden frame, or directly under the leather covering and, over time, the volatile DMF was evaporating and permeating the leather.
The release of DMF was then exacerbated by body temperature and perspiration, leading to levels adequate to cause sensitization. Anti-mould sachets are often used in conjunction with silica gel sachets, which contain an inert desiccant that removes moisture, but is relatively ineffective in the prevention of mould growth in large leather products. Although silica gel is inert and safe to use, BLC has found cases where the silica has combined with dimethyl fumarate and shown positive results when tested. In most cases, these were labelled as mould inhibitor sachets.

The law
On the basis of the research findings, France, Spain and Belgium adopted measures to regulate the use of DMF, and to ban the importation and placing on the market of products such as footwear containing DMF. The French Decree also orders the recall of all footwear and furniture products that visibly contain DMF in the product or packaging.
The Biocide Directive – 98/9/EEC – states that a biocidal product can only be used if ‘it has no unacceptable effects … on human health’4. Under this directive, products containing dimethyl fumarate are already banned for use in the European Union. This means that biocidal products containing DMF for use in manufacture and production of products within the EU are not legally available for protection against mould growth. However, this legislation does not cover the importation of products such as furniture, from countries outside the EU.
As a result of the severe cases of dermatitis caused by the presence of DMF in seating, the Commission of the European Communities proposed a ban in all products placed on the market. The restriction on use of DMF in products is governed by the Commission Decision 2009/251/EEC, and states that from May 1, 2009, all member states must ensure that any product containing DMF is withdrawn from the market. It also states that as of May 1, 2009, all products must comply with the limit of less than 0.1mg/kg of DMF per product or part of product. This was deemed to be sufficiently below the 1mg/kg level known to cause dermatitis in patch testing and, therefore, an adequate limit to address the associated risks.
Currently, there is no internationally recognised standard for the detection of DMF in sachets or leather. BLC has developed a method for detection of dimethyl fumarate and other fungicides with a reliable detection limit of less than 0.1mg/kg.

Dimethyl formamide
Within the footwear industry there has been some confusion as a result of another unrelated chemical having the abbreviation DMF, dimethyl formamide. Dimethyl formamide is a volatile organic compound with the chemical structure C3H7NO. The most common use of DMF is as a solvent in chemical reactions, primarily in the
production of plastics and polyurethane. It also has uses in the manufacture of adhesives, solvent dyes, synthetic leather and surface coatings. Exposure to DMF has been shown in studies by the US Environmental Protection Agency to cause dermatitis. However, this relates to acute exposure to DMF in its chemical form, and not to products and articles. The release of DMF into the environment is controlled in Europe under the Hazardous Waste Directive and there are currently no plans to restrict the use of DMF in the production of consumer articles.

Conclusion
Although DMF is already banned for use within the European Union, the publicity surrounding the cases of allergenic dermatitis caused by DMF-containing anti-mould sachets in furniture manufactured in China, has caused the European Commission to ban all products containing the
fungicide.
The ban and recall of products containing DMF is to be policed by individual EU member states, but it is important for importers, manufacturers and retailers to be aware of the risks and to address any issues raised. Problems, such as dermal irritation, caused by elevated levels of fungicides, can lead to brand damage and can potentially lead to high costs through proceedings with customers. BLC offers a validated analytical method for the detection and quantification of DMF which can be conducted within five days or less. BLC advises that due diligence testing of products or parts of products, such as materials prone to mould growth, packaging and silica gel sachets, be carried out. If a failure occurs BLC can offer specialist technical support.

References

1. J D L Williams et al, p 234, An outbreak of furniture dermatitis in the UK, British Journal of dermatology 2008, 159
2. T Rantanen, p 218, The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethyl fumarate, a novel potent contact sensitizer. British Journal of dermatology 2008, 159.
3. Williams, Op. cit, p 235.
4. Article 5(1)(b)(iii) of Directive 98/9/EEC, Official Journal of the European Union, L 123, 24.4.1998, p 8.